Literature DB >> 7579959

Timing of surgery in relation to the menstrual cycle and its influence on the survival of Japanese women with operable breast cancer.

J Kurebayashi1, H Sonoo, K Shimozuma.   

Abstract

It has been suggested that the timing of surgery during periods of unopposed estrogen circulation, when high blood levels of estrogen and low blood levels of progesterone exist, has a deleterious effect on the survival of premenopausal patients with breast cancer. We studied this controversial issue by examining the serum estradiol and progesterone levels of 38 premenopausal patients with primary breast cancer, and by analyzing data on 100 premenopausal patients treated for primary breast cancer. The survival of 31 patients who had undergone initial surgery between days 3 and 12 after their last menstrual period (group E) was compared with that of 69 patients who had undergone surgery between days 0 and 2 or from 13 days after their last menstrual period (group P). The overall survival of group E was significantly worse than that of group P (P = 0.049). This difference was especially notable in patients with node-positive tumors or tumors larger than 2 cm in size; however there was no significant difference in disease-free survival between the two groups. On a multivariate analysis, nodal status was the only significant prognostic factor for both overall and disease-free survival. Thus, these findings suggest that unopposed estrogen circulation may be detrimental to the overall survival of premenopausal women with breast cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579959     DOI: 10.1007/BF00311308

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  9 in total

1.  Optimal mastectomy timing.

Authors:  W L McGuire; S Hilsenbeck; G M Clark
Journal:  J Natl Cancer Inst       Date:  1992-03-04       Impact factor: 13.506

2.  Menstrual influence on surgical cure of breast cancer.

Authors:  W J Hrushesky; A Z Bluming; S A Gruber; R B Sothern
Journal:  Lancet       Date:  1989-10-21       Impact factor: 79.321

3.  Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer.

Authors:  R A Badwe; W M Gregory; M A Chaudary; M A Richards; A E Bentley; R D Rubens; I S Fentiman
Journal:  Lancet       Date:  1991-05-25       Impact factor: 79.321

4.  Association between timing of surgery during menstrual cycle and prognosis in pre-menopausal breast cancer.

Authors:  L A Marques; E L Franco
Journal:  Int J Cancer       Date:  1993-02-20       Impact factor: 7.396

5.  Optimal timing of breast cancer surgery: findings revive debate.

Authors:  N S Larsen
Journal:  J Natl Cancer Inst       Date:  1993-04-21       Impact factor: 13.506

6.  Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.

Authors:  K B Horwitz; G R Freidenberg
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

7.  Timing of surgery in relation to the menstrual cycle in premenopausal women with operable breast cancer.

Authors:  Z Saad; V Bramwell; J Duff; M Girotti; T Jory; G Heathcote; I Turnbull; B Garcia; L Stitt
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

Review 8.  Tamoxifen reduces serum insulin-like growth factor I (IGF-I).

Authors:  M N Pollak; H T Huynh; S P Lefebvre
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

9.  Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival.

Authors:  R T Senie; P P Rosen; P Rhodes; M L Lesser
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

  9 in total
  2 in total

1.  Timing of surgery during the menstrual cycle and prognosis of breast cancer.

Authors:  R A Badwe; I Mittra; R Havaldar
Journal:  J Biosci       Date:  2000-03       Impact factor: 1.826

Review 2.  Timing of breast surgery in premenopausal breast cancer patients.

Authors:  Miny Samuel; Khin Lay Wai; Victoria K Brennan; Wei Sean Yong
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.